Abstract:Min Li, 1 Fang-Jie Zhang, 2, 3 Rui-Jun Bai 1 1 Department of Orthopaedics, Wuxi Ninth People's Hospital, Soochow University, Wuxi, Jiangsu, 214000, People's Republic of China; 2 National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Changsha, Hunan, 410008, People's Republic of China; 3 Department of Emergency Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China Correspondence: Rui-Jun Bai, Department of Orthopaedics, Wuxi Ninth People's Hospital, Soochow University, Wuxi, People's Republic of China, Tel +86-15155580215, Fax +86-510-85867999, Email Fang-Jie Zhang, National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Changsha, Hunan, 410008, People's Republic of China, Tel +86-15116256248, Fax +86-871-84327332, Email Arthritis is the most prevalent joint disease and is characterized by articular cartilage degradation, synovial inflammation, and changes in periarticular and subchondral bone. Recent studies have reported that Yes-associated protein (YAP) and the transcriptional coactivator with PDZ-binding motif (TAZ) have significant effects on the proliferation, migration, and survival of chondrocytes and fibroblast-like synovial cells (FLSs). YAP/TAZ signaling pathway, as well as the related Hippo–YAP signaling pathway, are responsible for the condition of cells and articular cartilage in joints. They are tightly regulated to maintain metabolism in chondrocytes and FLSs because abnormal expression may result in cartilage damage. However, the roles and mechanisms of the Hippo–YAP pathway in arthritis remain largely unknown. This review summarizes the roles and key functions of YAP/TAZ and the Hippo–YAP signaling pathway in FLSs and chondrocytes for the induction of proliferation, migration, survival, and differentiation in rheumatoid arthritis (RA) and osteoarthritis (OA) research. We also discuss the therapeutic strategies involving YAP/TAZ and the related Hippo-YAP signaling pathway involved in OA. Keywords: YAP/TAZ, osteoarthritis, rheumatoid arthritis, chondrocytes, therapy Arthritis is the most common musculoskeletal disease in the world. Approximately 9% of the world's adult population is affected by osteoarthritis (OA), which mainly causes joint disability and predominantly affects the joints of the knee, hip and hand. 1,2 Radiographic evidence indicates that OA usually occurs in elderly individuals older than 65 years, while most of them are aged older than 75 years. 3,4 Although OA is often defined as a joint disease characterized by low-grade inflammation and cartilage destruction, its pathogenesis is complex and needs to be fully investigated. OA is a complex joint disorder in which a variety of pathogenic factors contribute to the pathological process. The common factors that induce the initiation and aggravation of OA include chronic mechanical stress, trauma and obesity, which lead to cartilage degeneration, synovial and joint inflammation, subchondral bone sclerosis, and osteophyte formation. 5–7 The extracellular matrix (ECM) and chondrocytes are the main components of articular cartilage, and their functional status is important for joints. Since articular cartilage has a limited capacity for intrinsic repair due to a lack of blood vessels and nerves, chondrocytes exiting only in the ECM are essential for joint health. 8–10 The morphology and function of chondrocytes are altered after receiving external or internal physical or chemical stimulation, leading to increased secretion of enzymes that promote the degradation of the cartilage matrix, such as matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs). 11–13 These enzymes mainly accelerated the degradation of OA and resulted in catabolic-degrading effects that overwhelm the anabolic-protective function of OA chondrocytes. A large number of proinflammatory cytokines, such as interleukin-1β (IL-1β), tumor necrosis factor (TNF-α) and IL-6, stimulate chondrocytes, and synovial cells secrete inflammatory factors to aggravate articular cartilage and synovial inflammatory responses and promote the progression of OA. 14,15 Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) activated by these inflammatory cytokines not only induce catabolic gene transcription but also stimulate inflammatory mediators such as TNF-α, IL-1β, and IL-6 to accelerate OA via feedback. 16 Recent studies have shown that synovial inflammation is also an important factor in the pathogenesis of rheumatoid arthritis (RA). 15,17,18 The synovial membrane is composed of fibroblast-like synovial cells (FLSs) that line the space betw -Abstract Truncated-

YAP-mediated regulation of the chondrogenic phenotype in response to matrix elasticity

Yap1 Regulates Multiple Steps of Chondrocyte Differentiation during Skeletal Development and Bone Repair

Reciprocal Inhibition of YAP/TAZ and NF-κB Regulates Osteoarthritic Cartilage Degradation

Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway

Microenvironmental mechanoactivation through Yap/Taz suppresses chondrogenic gene expression

Targeting Downstream Subcellular YAP Activity As a Function of Matrix Stiffness with Verteporfin-encapsulated Chitosan Microsphere Attenuates Osteoarthritis.

A Coordinated Phosphorylation By Lats And Ck1 Regulates Yap Stability Through Scf Beta-Trcp

Mechanical Loading Induces HIF-1α Expression in Chondrocytes Via YAP

YAP maintains cartilage stem/progenitor cell homeostasis in osteoarthritis

The Role of YAP Transcription Coactivator in Regulating Stem Cell Self-Renewal and Differentiation.

The effect of AKT in extracellular matrix stiffness induced osteogenic differentiation of hBMSCs

Tension regulates the cartilage phenotypic expression of endplate chondrocytes through the α‐catenin/actin skeleton/Hippo pathway

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

Liquid-Liquid Phase Separation of DDR1 Counteracts the Hippo Pathway to Orchestrate Arterial Stiffening

YAP1 regulates chondrogenic differentiation of ATDC5 promoted by temporary TNF-α stimulation through AMPK signaling pathway

The Hippo-YAP Signaling Pathway in Osteoarthritis and Rheumatoid Arthritis

Intermittent Hydrostatic Pressure Promotes Cartilage Repair in an Inflammatory Environment Through Hippo-YAP Signaling in Vitro and in Vivo

Yap and Taz promote osteogenesis and prevent chondrogenesis in neural crest cells in vitro and in vivo

LLPS of DDR1 Counteracts the Hippo Pathway to Orchestrate Arterial Stiffening

YAP and ECM Stiffness: Key Drivers of Adipocyte Differentiation and Lipid Accumulation

Inhibition of YAP with siRNA prevents cartilage degradation and ameliorates osteoarthritis development